ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ProPhase Labs, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 30 | 37 | +7 |
| Shares | 2.42M | 4.99M | +2.58M (+106.5%) |
| Value | $1.91M | $2.02M | +$103.5K (+5.4%) |
New holders (12)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wexford Capital LP | 1,525,611 | $616.8K | 0.16% |
| FourWorld Capital Management LLC | 376,577 | $152.3K | 0.10% |
| Quinn Opportunity Partners LLC | 318,127 | $128.6K | 0.01% |
| Citizens Financial Group Inc | 270,400 | $109.3K | 0.00% |
| Josh Arnold Investment Consultant, LLC | 250,000 | $100.0K | 0.08% |
| Cerity Partners LLC | 94,113 | $38.0K | 0.00% |
| Jane Street Group, LLC | 48,388 | $19.6K | 0.00% |
| JustInvest LLC | 32,418 | $13.1K | 0.00% |
| Barclays PLC | 12,572 | $5.08K | 0.00% |
| Ritholtz Wealth Management | 10,000 | $4.04K | 0.00% |
| Nordwand Advisors, LLC | 10,000 | $4.04K | 0.00% |
| Advisor Group Holdings, Inc. | 2,000 | $809 | 0.00% |
Sold out (5)
Institutions that held ProPhase Labs, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Warberg Asset Management LLC | 101,672 | $77.0K |
| Squarepoint Ops LLC | 52,394 | $39.7K |
| Engineers Gate Manager LP | 15,974 | $12.1K |
| Sykon Capital LLC | 12,700 | $9.62K |
| Tower Research Capital LLC (TRC) | 116 | $88 |